Fulgent Genetics, Inc. (FLGT)
NASDAQ: FLGT · Real-Time Price · USD
14.38
-0.50 (-3.36%)
At close: Mar 10, 2026, 4:00 PM EDT
14.27
-0.11 (-0.75%)
After-hours: Mar 10, 2026, 7:26 PM EDT

Revenue by Segment

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18 Dec '17 Dec '16
Therapeutic Development
447.00K----
Laboratory Services
322.22M283.47M289.21M618.97M992.58M
Laboratory Services Growth
13.67%-1.99%-53.27%-37.64%-
Total
322.67M283.47M289.21M618.97M992.58M
Total Growth
13.83%-1.99%-53.27%-37.64%135.37%

Revenue by Geography

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18 Dec '17 Dec '16
United States
296.55M259.13M268.98M603.15M978.98M
United States Growth
14.44%-3.66%-55.40%-38.39%135.71%
China
12.91M12.64M11.45M8.94M-
China Growth
2.12%10.41%28.05%--
Other Countries
13.21M11.70M8.79M6.88M-
Other Countries Growth
12.93%33.11%27.74%--
Foreign
----13.61M
Foreign Growth
----113.33%
Total
322.67M283.47M289.21M618.97M992.58M
Total Growth
13.83%-1.99%-53.27%-37.64%135.37%
Source: S&P Global Market Intelligence.